Free Trial
NASDAQ:MDCX

Medicus Pharma (MDCX) Stock Price, News & Analysis

Medicus Pharma logo
$2.54 +0.03 (+1.20%)
As of 10/3/2025 04:00 PM Eastern

About Medicus Pharma Stock (NASDAQ:MDCX)

Advanced

Key Stats

Today's Range
$2.42
$2.62
50-Day Range
$1.83
$2.80
52-Week Range
$1.79
$8.94
Volume
325,238 shs
Average Volume
411,235 shs
Market Capitalization
$45.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.50
Consensus Rating
Moderate Buy

Company Overview

Medicus Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

MDCX MarketRank™: 

Medicus Pharma scored higher than 58% of companies evaluated by MarketBeat, and ranked 467th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medicus Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Medicus Pharma has a consensus price target of $23.50, representing about 825.2% upside from its current price of $2.54.

  • Amount of Analyst Coverage

    Medicus Pharma has only been the subject of 3 research reports in the past 90 days.

  • Read more about Medicus Pharma's stock forecast and price target.
  • Earnings Growth

    Earnings for Medicus Pharma are expected to decrease in the coming year, from ($1.14) to ($1.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medicus Pharma is -1.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medicus Pharma is -1.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Medicus Pharma has a P/B Ratio of 8.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Medicus Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    13.52% of the float of Medicus Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Medicus Pharma has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medicus Pharma has recently decreased by 9.52%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Medicus Pharma does not currently pay a dividend.

  • Dividend Growth

    Medicus Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.52% of the float of Medicus Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Medicus Pharma has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medicus Pharma has recently decreased by 9.52%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Medicus Pharma has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Medicus Pharma this week, compared to 3 articles on an average week.
  • Search Interest

    41 people have searched for MDCX on MarketBeat in the last 30 days. This is an increase of 413% compared to the previous 30 days.
  • MarketBeat Follows

    40 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is an increase of 900% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medicus Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.20% of the stock of Medicus Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Medicus Pharma's insider trading history.
Receive MDCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDCX Stock News Headlines

D. Boral Capital Reaffirms Buy Rating for Medicus Pharma (NASDAQ:MDCX)
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
Medicus Pharma gets FDA backing to advance skin cancer patch
Medicus Pharma receives coverage from Stonegate Capital Partners
See More Headlines

MDCX Stock Analysis - Frequently Asked Questions

Medicus Pharma's stock was trading at $2.43 at the start of the year. Since then, MDCX stock has increased by 4.5% and is now trading at $2.54.

Medicus Pharma Ltd (NASDAQ:MDCX) announced its earnings results on Monday, August, 11th. The company reported ($0.43) earnings per share for the quarter, missing analysts' consensus estimates of ($0.39) by $0.04.

Medicus Pharma (MDCX) raised $4 million in an initial public offering on Thursday, November 14th 2024. The company issued 1,000,000 shares at a price of $4.13 per share. Maxim Group LLC acted as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/11/2025
Today
10/04/2025
Next Earnings (Estimated)
11/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDCX
Previous Symbol
NASDAQ:MDCX
CIK
1997296
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$27.00
Low Price Target
$20.00
Potential Upside/Downside
+825.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-549.30%
Return on Assets
-228.06%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.29
Quick Ratio
1.29

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
8.76

Miscellaneous

Outstanding Shares
17,816,000
Free Float
15,821,000
Market Cap
$45.25 million
Optionable
N/A
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MDCX) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners